RxDoctor Payments Data

Janet McNaughton, MD

Anatomic Pathology & Clinical Pathology · Fort Myers, FLNPI 1518118157

Payments from drug & device makers

$635in general payments, 2019–2025

Across 12 payments — averaging $52.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Adaptive Biotechnologies Corporation$286
  • Genentech USA, Inc.$122
  • Illumina, Inc.$118
  • Bristol Myers Squibb$47
  • Nanostring Technologies, Inc.$36
  • Bayer$13
  • plus $13 from 2 others

What the payments were for

  • Food & beverage$635100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Adaptive Biotechnologies Corporation3$286
Genentech USA, Inc.1$122
Illumina, Inc.2$118
Bristol Myers Squibb1$47
Nanostring Technologies, Inc.1$36
Bayer1$13
The Binding Site Inc.2$10
Veracyte, Inc.1$3

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$635 in reported general payments places this provider in the 80th percentile of 510 anatomic pathology & clinical pathology providers in Florida.

See all anatomic pathology & clinical pathology providers in Florida

Medicare billing

Part B allowed, 2024
$2,038,558
Medicare patients
14,963
Services billed
61,374

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Fort Myers

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →